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and easy to complete. The measure will be further tested in additional 
qualitative and quantitative studies to evaluate its measurement properties.  
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OBJECTIVES: There has been a growing interest in developing country-specific 
scoring algorithms for the EQ-5D around the world. This study systematically 
reviews all existing EQ-5D valuation studies to highlight their strengths and 
limitations, explores heterogeneity in observed utilities using meta-regression, 
and proposes a methodological checklist, the Checklist for Valuation Studies of 
the EQ-5D (CREATE) for reporting EQ-5D valuation studies. METHODS: We 
searched Medline, EMBASE, the National Health Service Economic Evaluation 
Database (NHS EED) via Wiley’s Cochrane Library, and Wiley’s Health Economic 
Evaluation Database from inception through November 2012, as well as 
bibliographies of key papers and the EuroQol Plenary Meeting Proceedings from 
1991 to 2012 for English-language reports of EQ-5D valuation studies. Two 
reviewers independently screened the titles and abstracts for relevance. Three 
reviewers performed data extraction and compared the characteristics and 
scoring algorithms developed in the included valuation studies. RESULTS: Of the 
31 studies included in the review, 19 used the time trade-off (TTO) technique, 10 
used the visual analogue scale (VAS) technique, and 2 used both TTO and VAS. 
Most studies used respondents from the general population selected by random 
or quota sampling, and face-to-face interviews or postal surveys. Studies valued 
between 7 and 198 total states, with 1 to 23 states valued per respondent. 
Different model specifications have been proposed for scoring. Some sample or 
demographic factors, including gender, education, per cent urban population, 
and national health care expenditure were associated with differences in 
observed utilities for moderate or severe health states. CONCLUSIONS: EQ-5D 
valuation studies conducted to date have varied widely in their design and in the 
resulting scoring algorithms. Therefore, we propose the CREATE for those 
conducting valuation studies.  
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OBJECTIVES: Consistency between translated clinical outcome assessments and 
corresponding rater training documentation is critical for global clinical trials. If 
the translation of rater training materials is completed independently or without 
reference to the linguistically validated clinical outcomes assessments, 
inconsistencies between the scale and the rater training materials are created. 
Steps must be taken to ensure consistency between rater training materials and 
their corresponding scales. METHODS: A review of prior projects involving rater 
training materials and corresponding scales, as well as discussion with Sponsors 
who have conducted translations with other organizations was conducted to 
provide insight into key areas where reference between the translation of the 
clinical outcomes assessment and the rater training material proved critical. 
RESULTS: Reviews of prior projects revealed that early reference to previously 
translated scales yielded improved linguistic consistencies between overlapping 
text found in rater training documentation, as well as yielding time efficiencies. 
If the rater training documentation was translated independently of the scale, 
inconsistencies existed between the scale and the rater training materials. This 
required additional reconciliation efforts, adding both timeline and cost to the 
project scope to rectify the inconsistencies. By centralizing the translation 
process for these documents, the inconsistencies were eliminated, and the 
additional cost and timeline for a secondary reconciliation process was avoided. 
CONCLUSIONS: It is important that the content used to train raters is consistent 
with the actual scale they will be using. If the translations are completed without 
reference to the scale, there will be inconsistent text that could ultimately 
confuse the rater and generate inaccurate results. Centralization of the rater 
training material translations and scale translations, or providing the translation 
provider completing the rater training documentation with the relevant scale 
translations for reference before project initiation, maximizes consistency 
between clinical outcome assessment translations and their corresponding rater 
training documentation.  
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OBJECTIVES: Researchers at Oxford are developing a new self-reported assessment 
tool called the e-Health Impact Questionnaire (e-HIQ), which will be used to assess 
the impact of using health-related websites. A translatability assessment was 
performed on the draft items to establish whether they will be cross-culturally and 
linguistically valid should the questionnaire be translated in the future. METHODS: 
A concept elaboration document was produced in order to expand on the items 
within the e-HIQ; this was sent to medical translators in six countries who provided 
feedback on the translatability of the text from linguistic and cultural perspectives. 
The project manager reviewed the recommendations from each translator and 
suggested changes to the e-HIQ developer. This was followed by a teleconference 
between the developer and the project manager, during which the suggested 
changes were discussed and implemented to ensure the e-HIQ will be more easily 
translated in the future. Finally, a report detailing the whole process was created 
and submitted to the developer. RESULTS: Several changes were deemed necessary 
as a result of the translatability assessment. These changes included clarifying the 
intended tense of ‘I may face’ in order to avoid mistranslation, and changing the 
phrase ‘taking steps’ to ‘taking actions’, retaining the positive tone yet avoiding a 
literal translation. There were also three questions that, although distinct in 
English, have overlapping meanings when translated. The questions included the 
terms ‘solidarity’, ‘have a lot in common’ and ‘identify with people’. Although clear 
terms in English, many languages only have one way of saying all three terms and 
therefore a change was advised. CONCLUSIONS: This study highlights the 
importance of including a translatability assessment during the development of a 
measure as it enables developers to incorporate an international element into its 
development. In turn, this will enable an easier transition into various translations.  
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OBJECTIVES: While requirements for identifying cognitive interviewing 
respondents are not specifically outlined in the FDA Guidance for Industry 
Patient-Reported Outcome Measures, best practices dictate that respondents 
should be as closely representative of the study patient population as possible. 
For a questionnaire intended for a single patient population or a study with a 
single patient population, this concept is sufficient for determining criteria. On 
the other hand, some cases lend themselves to the use of multiple patient 
populations and more varied respondent criteria. METHODS: Past translation 
and linguistic validation projects that included cognitive interviewing of multiple 
patient populations were reviewed along with the process for determining their 
respective respondent criteria. RESULTS: For each project, the goal of cognitive 
interviewing was to determine patient understanding of concepts in the 
intended study population. As such, respondent inclusion criteria were 
developed to represent the intended study population as closely as possible. 
Criteria ranged from multiple cancer types, to multiple age groups, as well as 
caregiver and patient mixtures. In each case, more than one respondent of each 
sub-category was required in order to ensure sufficient feedback. CONCLUSIONS: 
Cognitive interviewing of a single patient population typically includes around 5 
respondents. With multiple populations, an increased total number of 
respondents are recommended. Balancing this with study budget and timeline 
restrictions presents a challenge. While exact representation of multiple patient 
populations may not be possible, development of a more broadly representative 
criteria that still includes multiple populations proves beneficial in ensuring that 
a questionnaire is fit for purpose.  
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OBJECTIVES: The SF-36 and SF-12 are generic health-related quality of life 
(HRQoL) instruments used in many areas of research, including spinal cord 
injury (SCI). Repeated concerns have been raised within the broader disability 
literature about the appropriateness of such measures for subjects with 
significant physical impairment, yet continued use is widespread. This 
systematic review provides a comprehensive descriptive overview of how the SCI 
research community has adopted variants of the ‘short form’ HRQoL 
instruments. METHODS: A systematic database and bibliographic search was 
conducted to identify SCI-related publications reporting outcome data using a 
HRQoL instrument related to the 36-item and 12-item short form measures (e.g. 
SF-36, SF-12, RAND-36, RAND-12, SF-6D). Three descriptive considerations 
formed the basis of the analysis; 1) the frequency of use across identified 
variants; 2) the degree to which instruments have been administered as partial 
measures (i.e. selective use of items or domains); and 3) a summary of data 
collection methodology. RESULTS: One hundred seventy-four articles met the 
selection criteria. In total, 9 variants were identified; the SF-36 was the most 
widely used complete measure (n=76), followed by the SF-12 (n=24), SF-6D (n=4), 
RAND-36 (n=1), and VR-36 (n=2). Partial use of instruments was common (n=54); 
some studies identified limitations regarding the Physical Functioning scale and 
tested modified measures (n=13), such as the SF-36E and the SF-36WW. Data 
collection methodology was often ambiguous or missing (n=65). CONCLUSIONS: 
The SF-36 is a common HRQoL measure within SCI research, despite oft-cited 
concerns regarding its measurement properties. Attempts to add, delete or 
modify items have resulted in a large number of variants, often with minimal 
supportive psychometric evidence. Using established generic outcome measures 
is appealing because it enables comparisons to be made across clinical 
specialties. However, the trade-off between comparability and context-specific 
validity requires further explicit consideration within the SCI research.  
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